Jason Lettmann

Jason Lettmann is a Board Member at ALX Oncology. Jason has also served as the CEO & Board Member at Promedior, Inc., Board Member at Ra Pharmaceuticals, and Board Member at Vapotherm. Jason has also worked with Lightstone Ventures, Second Genome, Inc., and Relievant Medsystems, Inc. in the past. Jason is currently a Board Member at Morgenthaler Ventures.

Jason Lettmann has a MBA from the University of Michigan - Stephen M. Ross School of Business and a BA in Pre-medicine/Psychology from the University of Iowa.